Speed Remedies Private Limited

Speed Remedies Private Limited

Pharmaceutical company specializing in manufacturing, consulting, and processing of Indian and foreign drugs.
2006 | Vadodara, Gujarat (India) | Active

Last Updated:

June 29, 2024
HomeCompanySpeed Remedies Private Limited

Who are the key members and board of directors at Speed Remedies?

Board Members(4)

NameDesignationAppointment DateStatus
Bharat Shukal In Director 04-Dec-2006Current
Bharat Patel Us Director 19-May-2008Current
Manish Upadhyay Us Director 04-Dec-2006Current
Sunilkumar Shukal In Director 04-Dec-2006Current

Financial Performance of Speed Remedies.

Speed Remedies Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 23.02% decrease. The company also saw a substantial fall in profitability, with a 382.03% decrease in profit. The company's net worth moved up by a moderate rise of 1.63%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-23.02%
Revenue from Operations
-18.56%
Total Assets
-0.29%
Profit or Loss
-382.03%
Net Worth
1.63%
EBITDA
-45.36%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Speed Remedies?

Unlock and access historical data on people associated with Speed Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Speed Remedies

Recent activity within the organization

  • Annual General Meeting

    Speed Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Speed Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.

    31 Mar 2023

  • Director Appointment

    Bharat M Patel was appointed as a Director was appointed as a Director on 19 May 2008 & has been associated with this company since 16 years 7 months .

    19 May 2008

  • Director Appointment

    Bharat Bhalchandra Shukal was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 18 years 22 days .

    04 Dec 2006

  • Director Appointment

    Manish Upadhyay was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 18 years 22 days .

    04 Dec 2006

  • Director Appointment

    Sunilkumar Bhalchandra Shukal was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 18 years 22 days .

    04 Dec 2006

Frequently asked questions

  • Speed Remedies Private Limited was incorporated on 04 Dec 2006.

  • The authorized share capital of Speed Remedies Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 8.20 Cr.

  • Currently 4 directors are associated with Speed Remedies Private Limited.

    • Bharat Bhalchandra Shukal
    • Bharat M Patel
    • Manish Upadhyay
    • Sunilkumar Bhalchandra Shukal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Speed Remedies Private Limited is C-13 Dodsal Colony, Akota Road, Vadodara, Gujarat, India, 390007.

  • The corporate identification number (CIN) of Speed Remedies Private Limited is U24233GJ2006PTC049517 and the company number is 049517 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2016, the revenue trend for Speed Remedies Private Limited has fallen by -23.02%.

  • The financial reports for the fiscal year 2016 indicates that The net worth of Speed Remedies Private Limited has experienced an upsurge of 1.63%.

  • The most recent Balance Sheet for Speed Remedies Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development